Drugs / Triptoreline
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04242017 | Jul 2020 → Feb 2026 overdue | prostate cancer | Universitaire Ziekenhuizen KU Leuven | Recruiting | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT05352178 | Apr 2022 → Apr 2027 expected | metastatic malignant neoplasm, metastatic prostate carcinoma | Universitaire Ziekenhuizen KU Leuven | Recruiting | No outcome recorded |
| Phase 3 | NCT01973816 | Sep 2014 → Oct 2022 | endometriosis | University Hospital, Rouen | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00866008 | Oct 2008 → Jan 2011 | — | Bart CJM Fauser | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03307720 | Dec 2017 → Feb 2018 | female infertility, ovarian disorder | Ginegorama S.L. | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT01353846 Comparator | May 2011 → Nov 2012 | infertility disorder | Instituto Valenciano de Infertilidad, IVI VALENCIA | Unknown | No outcome recorded |
| Phase 4 | NCT00633347 Comparator | Jan 2007 → Oct 2009 | infertility disorder | Instituto Valenciano de Infertilidad, IVI VALENCIA | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triptoreline | “Arm B: gosereline 3.6 mg sc, leuproreline 7.5 mg sc, triptoreline 3.75 mg im Arm C: gosereline 3.6 mg sc 1x/month or gosereline 10.8 mg sc or leuproreline 7.5 mg sc 1x/month or...” NCT05352178 ↗6“administration of 0,2 mg of Triptoreline subcutaneously 36 hours prior to oocyte retrieval” NCT03307720 ↗ “Drugs: Agonist GnRH Acetate Triptoreline Acetate Triptorelina (Agonist GnRH), 3.75 mg.” NCT01353846 ↗ “Triptoreline (Decapeptyl)” NCT00866008 ↗ |
| Known as | Triptoreline (Decapeptyl) | “Triptoreline (Decapeptyl)” NCT00866008 ↗ |
| Action | Activate | “GnRH agonist” NCT00633347 ↗ |
| Route | Intramuscular | “administered in a single intramuscular injection (IM)” NCT00633347 ↗ |